Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 495 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Edgewise Therapeutics, Inc.
Market Cap
$4.34B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.21B
Operating Margin
-288.98%
TTM Avg
-690.34%
3Y Avg
-489.97%
5Y Avg
-306.42%
Market Cap
$4.49B
Operating Margin
21.39%
TTM Avg
12.04%
3Y Avg
0.21%
5Y Avg
0.61%
Market Cap
$4.50B
Operating Margin
-34.31%
TTM Avg
-42.52%
3Y Avg
-56.23%
5Y Avg
-56.23%
Market Cap
$4.78B
Operating Margin
-20.62%
TTM Avg
-55.73%
3Y Avg
-88.20%
5Y Avg
-107.26%
Market Cap
$4.81B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.92B
Operating Margin
-8739.34%
TTM Avg
-5186.54%
3Y Avg
-3135.16%
5Y Avg
-2237.88%
Market Cap
$5.02B
Operating Margin
10.90%
TTM Avg
-12.82%
3Y Avg
-40.85%
5Y Avg
-40.85%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.34B | 0.00% | 0.00% | 0.00% | 0.00% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.21B | -288.98% | -690.34% | -489.97% | -306.42% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.49B | 21.39% | 12.04% | 0.21% | 0.61% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | -34.31% | -42.52% | -56.23% | -56.23% |
| ICU Medical, Inc. (ICUI)vs › | $4.03B | 5.04% | 3.30% | 1.43% | 3.80% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | -20.62% | -55.73% | -88.20% | -107.26% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | 0.00% | 0.00% | 0.00% | 0.00% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | -8739.34% | -5186.54% | -3135.16% | -2237.88% |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 10.90% | -12.82% | -40.85% | -40.85% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.62B | -72.84% | -2371.95% | -1360.37% | -967.05% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
